Concord Biotech Faces Evaluation Shift Amid Declining Sales and Investor Stakes

Sep 03 2025 08:30 AM IST
share
Share Via
Concord Biotech has recently experienced a change in its evaluation, indicating a shift in market sentiment. The stock's price is slightly below its previous close, with a year-over-year return of -2.80%. The company reported a decline in quarterly net sales, while institutional ownership has also decreased.
Concord Biotech, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical landscape surrounding the stock, with indicators suggesting a transition from a bearish to a mildly bearish outlook.

The stock's current price stands at 1687.35, slightly below its previous close of 1693.05. Over the past year, Concord Biotech has experienced a return of -2.80%, while its profits have shown a modest increase of 13.7%. However, the company reported a significant decline in its quarterly performance, with net sales recorded at Rs 203.99 crore, marking a low point for the period.

Institutional investor participation has also seen a slight decrease, with a reduction of 0.54% in their stakes, bringing their collective ownership to 17.97%. Despite a high return on equity of 18.1%, the stock is perceived as having a premium valuation compared to its peers.

Overall, the recent evaluation adjustment highlights the evolving dynamics within Concord Biotech, reflecting both technical trends and broader market conditions.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News